companydata.dkGXP PHARMAID ApS: Financial statements 2015
CVR: 29615861
GXP PHARMAID ApS (CVR 29615861) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 1,896,044 and a net result of DKK -667,129 compared with DKK 380,379 the year before. That is a decrease of 47.4% compared with the year before. Equity amounted to DKK 447,019. The solvency ratio was 26.8%.
- Gross Profit
- 1,896,044 kr.
- Profit/Loss
- -667,129 kr.
- Equity
- 447,019 kr.
- Total Assets
- 1,670,903 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 1.9 mio. | -667 t. | 447 t. | - |
| 2014 | - | 3.6 mio. | 380 t. | 1.1 mio. | - |
| 2013 | - | 2.3 mio. | 451 t. | 1.1 mio. | - |
| 2012 | - | 2.1 mio. | - | - | - |
Events in 2015
GXP PHARMAID ApS has published its annual report for 2014. Gross profit came to DKK 3,604,083, and the net result was DKK 380,379.
About GXP PHARMAID ApS
GXP PHARMAID ApS is a Danish company of the type Anpartsselskab based in Brønshøj, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Nusret Asanovski. The company is owned by MAC ANDORBY ApS. The company has 2 employees. In 2024, the company reported a gross profit of DKK 1,340,825 and a net result of DKK 216,532 compared with DKK 513,163 the year before. Equity amounted to DKK 1,096,211.